Cheng Jiang

Mr. Cheng Jiang

orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 March 2023 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
THTodd Hollon
Todd Hollon
CJCheng Jiang
Cheng Jiang
ACAsadur Chowdury
Asadur Chowdury
MNMustafa Nasir-Moin
Mustafa Nasir-Moin
AKAkhil Kondepudi
Akhil Kondepudi
DODaniel A. Orringer
Daniel A. Orringer

13 November 2024 in Nature
Verified
Journal Article
Open access
PDF file
AKAkhil Kondepudi
Akhil Kondepudi
MPMelike Pekmezci
Melike Pekmezci
XHXinhai Hou
Xinhai Hou
KSKatie Scotford
Katie Scotford
CJCheng Jiang
Cheng Jiang
THTodd Hollon
Todd Hollon
A critical challenge in glioma treatment is detecting tumour infiltration during surgery to achieve safe maximal resection1,2,3. Unfortunately, safely resectable residual tumour is found in the majority of patients with glioma after surgery, causing early recurrence and decreased survival4,5,6. Here we present FastGlioma, a visual foundation model for fast (<10 s) and accurate detection of glioma infiltration in fresh, unprocessed surgical tissue. FastGlioma was pretrained using large-scale self-supervision (around 4 million images) on rapid, label-free optical microscopy, and fine-tuned to output a normalized score that indicates the degree of tumour infiltration within whole-slide optical images. In a prospective, multicentre, international testing cohort of patients with diffuse glioma (n = 220), FastGlioma was able to detect and quantify the degree of tumour infiltration with an average area under the receiver operating characteristic curve of 92.1 ± 0.9%. FastGlioma outperformed image-guided and fluorescence-guided adjuncts for detecting tumour infiltration during surgery by a wide margin in a head-to-head, prospective study (n = 129). The performance of FastGlioma remained high across diverse patient demographics, medical centres and diffuse glioma molecular subtypes as defined by the World Health Organization. FastGlioma shows zero-shot generalization to other adult and paediatric brain tumour diagnoses, demonstrating the potential for our foundation model to be used as a general-purpose adjunct for guiding brain tumour surgeries. These findings represent the transformative potential of medical foundation models to unlock the role of artificial intelligence in the care of patients with cancer.

30 September 2020 in Diagnostics
Verified
Journal Article
Open access
PDF file
NFNegar Farzaneh
Negar Farzaneh
CWCraig A. Williamson
Craig A. Williamson
CJCheng Jiang
Cheng Jiang
ASAshok Srinivasan
Ashok Srinivasan
JBJayapalli R. Bapuraj
Jayapalli R. Bapuraj
SSS.M.Reza Soroushmehr
S.M.Reza Soroushmehr
Detection and severity assessment of subdural hematoma is a major step in the evaluation of traumatic brain injuries. This is a retrospective study of 110 computed tomography (CT) scans from patients admitted to the Michigan Medicine Neurological Intensive Care Unit or Emergency Department. A machine learning pipeline was developed to segment and assess the severity of subdural hematoma. First, the probability of each point belonging to the hematoma region was determined using a combination of hand-crafted and deep features. This probability provided the initial state of the segmentation. Next, a 3D post-processing model was applied to evolve the initial state and delineate the hematoma. The recall, precision, and Dice similarity coefficient of the proposed segmentation method were 78.61%, 76.12%, and 75.35%, respectively, for the entire population. The Dice similarity coefficient was 79.97% for clinically significant hematomas, which compared favorably to an inter-rater Dice similarity coefficient. In volume-based severity analysis, the proposed model yielded an F1, recall, and specificity of 98.22%, 98.81%, and 92.31%, respectively, in detecting moderate and severe subdural hematomas based on hematoma volume. These results show that the combination of classical image processing and deep learning can outperform deep learning only methods to achieve greater average performance and robustness. Such a system can aid critical care physicians in reducing time to intervention and thereby improve long-term patient outcomes.

1 June 2023
Verified
Conference Paper
Closed access
CJCheng Jiang
Cheng Jiang
XHXinhai Hou
Xinhai Hou
AKAkhil Kondepudi
Akhil Kondepudi
ACAsadur Chowdury
Asadur Chowdury
CFChristian W. Freudiger
Christian W. Freudiger
THTodd C. Hollon
Todd C. Hollon
Learning high-quality, self-supervised, visual representations is essential to advance the role of computer vision in biomedical microscopy and clinical medicine. Previous work has focused on self-supervised representation learning (SSL) methods developed for instance discrimination and applied them directly to image patches, or fields-of-view, sampled from gigapixel whole-slide images (WSIs) used for cancer diagnosis. However, this strategy is limited because it (1) assumes patches from the same patient are independent, (2) neglects the patient-slide-patch hierarchy of clinical biomedical microscopy, and (3) requires strong data augmentations that can degrade downstream performance. Importantly, sampled patches from WSIs of a patient's tumor are a diverse set of image examples that capture the same underlying cancer diagnosis. This motivated HiDisc, a data-driven method that leverages the inherent patient-slide-patch hierarchy of clinical biomedical microscopy to define a hierarchical discriminative learning task that implicitly learns features of the underlying diagnosis. HiDisc uses a self-supervised contrastive learning framework in which positive patch pairs are defined based on a common ancestry in the data hierarchy, and a unified patch, slide, and patient discriminative learning objective is used for visual SSL. We benchmark HiDisc visual representations on two vision tasks using two biomedical microscopy datasets, and demonstrate that (1) HiDisc Pre-training outperforms current state-of-the-art self-supervised Pre-training methods for cancer diagnosis and genetic mutation prediction, and (2) HiDisc learns high-quality visual representations using natural patch diversity without strong data augmentations.

1 January 2022 in Advances in neural information processing systems
Verified
Conference Paper
Closed access
CJCheng Jiang
Cheng Jiang
ACAsadur Chowdury
Asadur Chowdury
XHXinhai Hou
Xinhai Hou
AKAkhil Kondepudi
Akhil Kondepudi
CFChristian Freudiger
Christian Freudiger
THTodd Hollon
Todd Hollon
Accurate intraoperative diagnosis is essential for providing safe and effective care during brain tumor surgery. Our standard-of-care diagnostic methods are time, resource, and labor intensive, which restricts access to optimal surgical treatments. To address these limitations, we propose an alternative workflow that combines stimulated Raman histology (SRH), a rapid optical imaging method, with deep learning-based automated interpretation of SRH images for intraoperative brain tumor diagnosis and real-time surgical decision support. Here, we present OpenSRH, the first public dataset of clinical SRH images from 300+ brain tumors patients and 1300+ unique whole slide optical images. OpenSRH contains data from the most common brain tumors diagnoses, full pathologic annotations, whole slide tumor segmentations, raw and processed optical imaging data for end-to-end model development and validation. We provide a framework for patch-based whole slide SRH classification and inference using weak (i.e. patient-level) diagnostic labels. Finally, we benchmark two computer vision tasks: multiclass histologic brain tumor classification and patch-based contrastive representation learning. We hope OpenSRH will facilitate the clinical translation of rapid optical imaging and real-time ML-based surgical decision support in order to improve the access, safety, and efficacy of cancer surgery in the era of precision medicine. Dataset access, code, and benchmarks are available at https://opensrh.mlins.org.

6 February 2026 in Nature Biomedical Engineering
Verified
Journal Article
Closed access
YLYiwei Lyu
Yiwei Lyu
SHSamir Harake
Samir Harake
ACAsadur Chowdury
Asadur Chowdury
SBSoumyanil Banerjee
Soumyanil Banerjee
RGRachel Gologorsky
Rachel Gologorsky
THTodd Hollon
Todd Hollon